|
Volumn 23, Issue 2, 2013, Pages 488-491
|
Dual action spirobicycloimidazolidine-2,4-diones: Antidiabetic agents and inhibitors of aldose reductase-an enzyme involved in diabetic complications
|
Author keywords
Aldose reductase; Diabetic complications; Enzyme inhibition; Hypoglycemic agents; Imidazolidinediones
|
Indexed keywords
ALDEHYDE REDUCTASE;
ALDOSE REDUCTASE INHIBITOR;
ANTIDIABETIC AGENT;
CAMPHOR;
CHLORIDE;
GLIBENCLAMIDE;
GLUCOSE;
IMIDAZOLIDINE DERIVATIVE;
SPIRO COMPOUND;
SPIROBICYCLOIMIDAZOLIDINE 2,4 DIONE DERIVATIVE;
SULINDAC;
UNCLASSIFIED DRUG;
VALPROIC ACID;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIDIABETIC ACTIVITY;
ARTICLE;
CARBON NUCLEAR MAGNETIC RESONANCE;
CONTROLLED STUDY;
DRUG POTENCY;
DRUG SCREENING;
DRUG SYNTHESIS;
ENZYME INHIBITION;
ENZYME KINETICS;
GLUCOSE BLOOD LEVEL;
IC 50;
IN VIVO STUDY;
MALE;
NONHUMAN;
PROTON NUCLEAR MAGNETIC RESONANCE;
RAT;
STRUCTURE ACTIVITY RELATION;
ALDEHYDE REDUCTASE;
ANIMALS;
BLOOD GLUCOSE;
DIABETES COMPLICATIONS;
DIABETES MELLITUS;
DIABETES MELLITUS, EXPERIMENTAL;
ENZYME ACTIVATION;
HUMANS;
HYDANTOINS;
HYPOGLYCEMIC AGENTS;
INHIBITORY CONCENTRATION 50;
|
EID: 84871713303
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2012.11.039 Document Type: Article |
Times cited : (36)
|
References (22)
|